Get the latest Science News and Discoveries

Insilico Medicine Founder and CEO Alex Zhavoronkov, PhD talks about AI and robotics in healthcare breakthroughs in ... - EurekAlert


Alex Zhavoronkov, PhD, founder and co-CEO of Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, will be attending a series of meetings in the following week, where he will be discussing bioscience innovations powered by AI and robotics.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of Robotics

Robotics

Photo of CEO Alex Zhavoronkov

CEO Alex Zhavoronkov

Photo of PhD talks

PhD talks

Related news:

News photo

Digital babies created to improve infant healthcare - EurekAlert

News photo

Heat-switch device boosts lunar rover longevity in harsh Moon climate - EurekAlert

News photo

Fat molecule's inability to bond with shape-shifting protein in cell's powerhouse linked to an inherited metabolic disease - EurekAlert